Controlling the Growth of the Skin Commensal Staphylococcus epidermidis Using d-Alanine Auxotrophy.

MSphere
David DoddsTravis M Whitfill

Abstract

Using live microbes as therapeutic candidates is a strategy that has gained traction across multiple therapeutic areas. In the skin, commensal microorganisms play a crucial role in maintaining skin barrier function, homeostasis, and cutaneous immunity. Alterations of the homeostatic skin microbiome are associated with a number of skin diseases. Here, we present the design of an engineered commensal organism, Staphylococcus epidermidis, for use as a live biotherapeutic product (LBP) candidate for skin diseases. The development of novel bacterial strains whose growth can be controlled without the use of antibiotics or genetic elements conferring antibiotic resistance enables modulation of therapeutic exposure and improves safety. We therefore constructed an auxotrophic strain of S. epidermidis that requires exogenously supplied d-alanine. The S. epidermidis NRRL B-4268 Δalr1 Δalr2 Δdat strain (SEΔΔΔ) contains deletions of three biosynthetic genes: two alanine racemase genes, alr1 and alr2 (SE1674 and SE1079), and the d-alanine aminotransferase gene, dat (SE1423). These three deletions restricted growth in d-alanine-deficient medium, pooled human blood, and skin. In the presence of d-alanine, SEΔΔΔ colonized and increased expressi...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 11, 2003·Clinical and Diagnostic Laboratory Immunology·James G H DinulosGary L Darmstadt
Jan 28, 2003·Annals of Botany·Xinyou YinHuub J Spiertz
Dec 2, 2004·Acta Microbiologica Et Immunologica Hungarica·A PivarcsiA Dobozy
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Dec 19, 2007·European Journal of Dermatology : EJD·Kenshi Yamasaki, Richard L Gallo
Sep 10, 2008·Antimicrobial Agents and Chemotherapy·Jonas LannergårdDiarmaid Hughes
Sep 11, 2008·Infectious Disorders Drug Targets·Birgit SchittekHeiko Steffen
Jan 20, 2009·Current Pharmaceutical Biotechnology·M C F BastosJ S Nascimento
Feb 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·William R WikoffGary Siuzdak
Oct 27, 2009·Nature Immunology·Nita H SalzmanNicolaas A Bos
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jacques RavelLarry J Forney
Nov 5, 2010·The Journal of Investigative Dermatology·Ines WankeBirgit Schittek
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rochellys Diaz HeijtzSven Pettersson
Mar 17, 2011·Nature Reviews. Microbiology·Elizabeth A Grice, Julia A Segre
Jun 17, 2011·Nature·Andrew L KauJeffrey I Gordon
Jul 26, 2011·Microbes and Infection·María Sol BarbagelataFernanda Buzzola
Jul 28, 2012·Science·Shruti NaikYasmine Belkaid
Jan 17, 2013·Acta Dermato-venereologica·Saba M Ali, Gil Yosipovitch
Jan 29, 2013·Applied and Environmental Microbiology·Jeffrey L BoseKenneth W Bayles
Aug 24, 2013·The Journal of Biological Chemistry·Chen ChenOlaf Schneewind
Jan 18, 2014·Pathogens and Disease·Ilse VandecandelaereTom Coenye
Mar 13, 2014·Experimental Dermatology·Maren SimanskiJürgen Harder
Apr 12, 2014·Nature Reviews. Immunology·Manolis PasparakisFrank O Nestle
Aug 3, 2014·Seminars in Cutaneous Medicine and Surgery·Elizabeth A Grice

❮ Previous
Next ❯

Datasets Mentioned

BETA
AE015929
CP043845
GM2163

Methods Mentioned

BETA
PCR
gene knockout
PCRs
gene
biopsy

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.